Web support for the more efficient discovery of kinase inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Web support for the more efficient discovery of kinase inhibitors

Published:2022-08 Issue:8 Volume:27 Page:2216-2225
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Chen Yi,Wang Zhi-Zheng,Hao Ge-Fei,Song Bao-An

Funder

National Key Research and Development Program of China

Project 211

Higher Education Discipline Innovation Project

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference70 articles.

1. Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer;Momcilovic;Cell Rep,2017

2. The protein kinase complement of the human genome;Manning;Science,2002

3. Targeting cancer with small molecule kinase inhibitors;Zhang;Nat Rev Cancer,2009

4. Properties of FDA-approved small molecule protein kinase inhibitors: a 2021 update;Roskoski;Pharmacol Res,2021

5. Exploration of a binding mode of benzothiazol-2-yl acetonitrile pyrimidine core based derivatives as potent c-Jun N-terminal kinase-3 inhibitors and 3D-QSAR analyses;Sharma;J Chem Inf Model,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinase Drug Discovery: Impact of Open Science and Artificial Intelligence;Molecular Pharmaceutics;2024-09-06

2. Data-oriented protein kinase drug discovery;European Journal of Medicinal Chemistry;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP